Delivery Order SPE2DB22D2206-SPE2DB26FDS18
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Lidocaine 5% Patch 30s with a ceiling value of $13,771.20. This is a firm fixed price delivery order with an ultimate completion date of August 25, 2025, and represents a competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Lidocaine 5% Patch in quantities of 30 units, with a ceiling value of $10,360.64. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The award carries an ultimate completion date of August 11, 2025,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Lidocaine 5% patches in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $10,866.10 and an ultimate completion date of August 29, 2025. The contract carries no set-aside designation and was awarded competitively. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a firm fixed-price delivery order valued at $2,722.08 for Lidocaine 5% Patch 30-count units, with an ultimate completion date of August 22, 2025. This non-set-aside competitive award was issued on August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the prime...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for Lidocaine 5% Patch 30-count units with a ceiling value of $26,828.37. This firm fixed-price delivery order, which is due for completion by August 28, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for Lidocaine 5% Patch 30-count units, with a ceiling value of $1,577.57 and an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Lidocaine 5% Patch (30-count units) under a firm fixed-price arrangement with a ceiling value of $1,412.04. The contract, which is not set-aside and was competitively awarded, represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This underlying prime IDV, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This firm fixed-price delivery order, valued at $1,622.36, represents a non-competitive set-aside contract and is scheduled for completion by August 19, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate operations. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Lidocaine 5% Patch in quantities of 30 units. This is a firm fixed price delivery order with a ceiling value of $2,596.62 and a completion date of September 8, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $1,362.48 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-count packages of Lidocaine 5% Patch on September 26, 2025, with an ultimate completion date of September 29, 2025. This non-set-aside contract was competitively awarded to support federal medical supply requirements. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB26FDS18Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 20, 2025, for Lidocaine 5% patches (30-count packaging) with a ceiling value of $1,623.64 and a firm fixed price structure. This is a non-set-aside, competitively awarded contract with an ultimate completion date of October 21, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, supplying a wide range of medications and medical supplies to military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's federal contract portfolio demonstrates significant capability in delivering diverse pharmaceutical products including specialty medications, generic drugs, vaccines, and medical devices across multiple therapeutic areas. The Lidocaine patch delivery order represents a routine pharmaceutical supply need within the broader DLA global pharmaceutical support framework designed to sustain military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 10/20/25 |